BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4978460)

  • 1. A controlled clinical trial of the drug treatment of new cases of pulmonary tuberculosis.
    Böszörményi M; Schweiger O
    Scand J Respir Dis Suppl; 1968; 65():189-93. PubMed ID: 4978460
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
    Tubercle; 1973 Jun; 54(2):99-129. PubMed ID: 4203162
    [No Abstract]   [Full Text] [Related]  

  • 3. A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.
    Ramakrishnan CV; Devadatta S; Evans C; Fox W; Menon NK; Nazareth O; Radhakrishna S; Sambamoorthy S; Stott H; Tripathy SP; Velu S
    Tubercle; 1969 Jun; 50(2):115-24. PubMed ID: 4892322
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of two regimens of simplified two-stage chemotherapy in previously untreated pulmonary tuberculosis.
    Bethlem N; Gerhardt FO G; Magarăo S
    Tubercle; 1973 Sep; 54(3):180-4. PubMed ID: 4204111
    [No Abstract]   [Full Text] [Related]  

  • 5. [[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
    Kekkaku; 1971 Aug; 46(8):325-33. PubMed ID: 4998863
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
    [No Abstract]   [Full Text] [Related]  

  • 7. The syndrome of open cavity healing.
    Zierski M
    Scand J Respir Dis Suppl; 1968; 65():151-6. PubMed ID: 4978459
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar; 54(1):23-45. PubMed ID: 4204397
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the clinical usefulness of ethionamide and prothionamide in initial treatment of tuberculosis: tenth series of controlled trials.
    Tubercle; 1968 Sep; 49(3):281-90. PubMed ID: 4884773
    [No Abstract]   [Full Text] [Related]  

  • 10. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):39-45. PubMed ID: 4979932
    [No Abstract]   [Full Text] [Related]  

  • 11. Follow-up of positive cases of pulmonary tuberculosis diagnosed in 1957.
    Christensen O
    Scand J Respir Dis Suppl; 1968; 63():9-28. PubMed ID: 4972112
    [No Abstract]   [Full Text] [Related]  

  • 12. The antituberculosis efficacy of rifampin in 136 patients.
    Davidson PT; Goble M; Lester W
    Chest; 1972 Jun; 61(6):574-8. PubMed ID: 4624279
    [No Abstract]   [Full Text] [Related]  

  • 13. Productivity of prolonged follow-up after chemotherapy for tuberculosis.
    Stead WW; Jurgens GH
    Am Rev Respir Dis; 1973 Aug; 108(2):314-20. PubMed ID: 4198349
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial.
    Boman G
    Chest; 1972 Jun; 61(6):533-8. PubMed ID: 5032151
    [No Abstract]   [Full Text] [Related]  

  • 15. Streptomycin plus thiacetazone (thioacetazone) compared with streptomycin plus PAS and with isoniazid plus thiacetazone in the treatment of pulmonary tuberculosis in Rhodesia.
    Briggs IL; Rochester WR; Shennan DH; Riddell RW; Fox W; Heffernan JF; Miller AB; Nunn AJ; Stott H; Tall R
    Tubercle; 1968 Mar; 49(1):48-69. PubMed ID: 4173466
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance.
    Tripathy SP; Menon NK; Mitchison DA; Narayana AS; Somasundaram PA; Stott H; Velu S
    Tubercle; 1969 Sep; 50(3):257-68. PubMed ID: 4981496
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of acceptable and adequate outpatient treatment on the length of hospitalization and on readmission for relapse or reactivation of pulmonary tuberculosis.
    Curry FJ
    Chest; 1973 Apr; 63(4):536-46. PubMed ID: 4633013
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
    Favez G; Chioléro R; Willa C
    Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis.
    Bobrowitz ID; Robins DE
    Am Rev Respir Dis; 1967 Sep; 96(3):428-38. PubMed ID: 6039097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.